Skip to main content
Beverly Tchang, MD, Endocrinology, New York, NY

BeverlyTchangMDDABOM

Endocrinology New York, NY

Diabetes, Obesity

Assistant Professor of Clinical Medicine

Overview of Dr. Tchang

Dr. Beverly Tchang is an endocrinologist in New York, NY and is affiliated with multiple hospitals in the area, including NewYork-Presbyterian/Weill Cornell and New York-Presbyterian Hospital. She received her medical degree from State University of New York Downstate Medical Center College of Medicine and has been in practice 6 years. She specializes in diabetes, lipid metabolism, and obesity and is experienced in nutrition, obesity and obesity-related disorders, and menopause.

Education & Training

  • New York Presbyterian Hospital
    New York Presbyterian HospitalFellowship, Obesity Medicine, 2018 - 2019
  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Fellowship, Endocrinology, Diabetes, and Metabolism, 2016 - 2018
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2013 - 2016
  • State University of New York Downstate Medical Center College of Medicine
    State University of New York Downstate Medical Center College of MedicineClass of 2013, MD, AOA

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • NY State Medical License
    NY State Medical License 2017 - 2026
  • NJ State Medical License
    NJ State Medical License 2022 - 2023
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
  • American Board of Obesity Medicine Obesity Medicine
  • North American Menopause SocietyCertified Menopause Practitioner

Publications & Presentations

PubMed

Authored Content

  • Obesity Management - A Clinical Casebook, Chapters 11-12January 2019

Press Mentions

  • What to Know About the New Heart Disease Risk Measurement
    What to Know About the New Heart Disease Risk MeasurementOctober 25th, 2024
  • Tirzepatide Shortage Resolved? FDA Says Yes, Compounders No
    Tirzepatide Shortage Resolved? FDA Says Yes, Compounders NoOctober 7th, 2024
  • These 4 Factors Can Impact How Many Pounds You'll Lose on Weight Loss Drugs like Ozempic
    These 4 Factors Can Impact How Many Pounds You'll Lose on Weight Loss Drugs like OzempicSeptember 17th, 2024
  • Join now to see all